硫酸镁联合孟鲁司特治疗小儿喘息性支气管肺炎疗效分析
2020-12-23顾梅青
顾梅青


[摘要] 目的 分析硫酸鎂联合孟鲁司特治疗小儿喘息性支气管肺炎的临床疗效。方法 方便选择98例小儿喘息性支气管肺炎患儿为研究对象,时间段为2017年3月—2019年5月。根据不同的药物使用,将所有患儿分为对照组和观察组,各49例。对照组患儿采用硫酸镁药物治疗,观察组患儿实施孟鲁司特联合硫酸镁治疗。比较两组患儿治疗前后的喘息症状评分和喘息发作次数,对比两组患儿的临床疗效。结果 治疗后,对照组的喘息症状评分为(5.49±3.10)分,显著高于观察组的(2.73±1.78)分,差异有统计学意义(t=5.405,P<0.05);在喘息发作次数方面,对照组的发作次数为(1.31±0.96)次,也明显多于观察组的(0.33±0.20)次,差异有统计学意义(t=6.996,P<0.05)。同时,在临床疗效方面,对照组的治疗总有效率为79.59%(39/49),观察组的治疗总有效率为95.92%(47/49),两组之间差异有统计学意义(χ2=6.078,P=0.014)。 结论 对小儿喘息性支气管肺炎患儿实施硫酸镁联合孟鲁司特治疗,能显著改善患儿的临床症状,降低患儿喘息的发作次数,治疗效果甚为理想。
[关键词] 硫酸镁;孟鲁司特;小儿喘息性支气管肺炎;疗效
[中图分类号] R542.22 [文献标识码] A [文章编号] 1674-0742(2020)06(b)-0109-03
[Abstract] Objective To analyze the clinical effect of magnesium sulfate combined with montelukast in the treatment of asthmatic bronchopneumonia in children. Methods 98 children with wheezing broncho pneumonia were selected as the research subjects, and the time period was convenient from March 2017 to May 2019. According to different drug use, all children were divided into control group and observation group, 49 cases each. The children in the control group were treated with magnesium sulfate, and the children in the observation group were treated with montelukast combined with magnesium sulfate. The wheezing symptom score and the number of wheezing attacks before and after treatment were compared between the two groups, and the clinical efficacy of the two groups was compared. Results After treatment, the wheezing symptom score of the control group was (5.49 ± 3.10)points, which was significantly higher than that of the observation group (2.73±1.78)points, the difference was statistically significant (t=5.405, P<0.05); in terms of the number of wheezing attacks, the number of attacks in the control group was (1.31±0.96)times, which was also significantly higher than that in the observation group (0.33±0.20)times, the difference was statistically significant (t=6.996, P<0.05). At the same time, in terms of clinical efficacy, the total effective rate of treatment in the control group was 79.59% (39/49), and the total effective rate of treatment in the observation group was 95.92% (47/49). The difference between the two groups was statistical significance (χ2=6.078, P=0.014). Conclusion The treatment of children with asthmatic bronchopneumonia by magnesium sulfate combined with montelukast can significantly improve the clinical symptoms of children and reduce the number of wheezing episodes in children. The treatment effect is ideal.
[Key words] Magnesium sulfate; Montelukast; Pediatric asthmatic bronchopneumonia; Efficacy
小儿喘息性支气管肺炎是儿童时期较为常见的慢性呼吸道疾病,在医学上被归属于气道慢性炎症的范畴之内,其临床表现主要为反复咳嗽、喘鸣、咳痰和呼吸困难等,长期的病情发作会严重威胁患儿的身心健康,影响患儿的成长发育。数据表明,近年来,小儿喘息性支气管肺炎的发病率正在逐年上升,加之此类疾病具有反复发作和病程时间长的特点,已成为全世界儿科的关注重点。众所周知,硫酸镁是治疗小儿喘息性支气管肺炎的常用药物,在扩张支气管、改善通气功能等方面,积极作用极为明显。资料显示,白三烯是引发小儿哮喘的重要原因,可促使支气管分泌过多的粘液,导致患儿的支气管出现痉挛,进而发生呼吸困难。为此,采用白三烯受体拮抗剂来对哮喘患儿实施疾病治疗,也成为了临床的常用手段,并随着医学技术的进步和医学理念的不断开放,应用范围正在不断扩大。……
